Literature DB >> 7492204

Indications for investigation of chronic gastrointestinal symptoms.

R M Beattie1, J A Walker-Smith, S H Murch.   

Abstract

Simple routine blood tests (full blood count, platelet count, erythrocyte sedimentation rate, C reactive protein, and serum albumin) may select children with chronic gastrointestinal symptoms who require endoscopic assessment and are thus an important aid in the prediction of endoscopic status. When all of the results are normal then chronic inflammatory bowel disease is an unlikely diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 7492204      PMCID: PMC1511324          DOI: 10.1136/adc.73.4.354

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Platelet count: a simple measure of activity in Crohn's disease.

Authors:  A D Harries; E Fitzsimons; R Fifield; M J Dew; J Rhoades
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-07

2.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

3.  Acute phase proteins in chronic inflammatory bowel disease in childhood.

Authors:  C A Campbell; J A Walker-Smith; P Hindocha; M Adinolfi
Journal:  J Pediatr Gastroenterol Nutr       Date:  1982       Impact factor: 2.839

4.  Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis.

Authors:  P I Macfarlane; V Miller; F Wells; B Richards
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986-01       Impact factor: 2.839

5.  C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders.

Authors:  B Shine; L Berghouse; J E Jones; J Landon
Journal:  Clin Chim Acta       Date:  1985-05-30       Impact factor: 3.786

  5 in total
  24 in total

Review 1.  Chronic inflammatory bowel disease in children: a complex problem in management.

Authors:  J A Walker-Smith
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

2.  Appropriate investigation of inflammatory bowel disease in children.

Authors:  M D Stringer; T Randall; D P Rutter; S V Picton; J W Puntis
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

Review 3.  Therapy of Crohn's disease in childhood.

Authors:  R M Beattie
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 4.  Inflammatory bowel disease.

Authors:  R M Beattie; N M Croft; J M Fell; N A Afzal; R B Heuschkel
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

5.  Measurement of Fractional Exhaled Nitric Oxide as a Marker of Disease Activity in Inflammatory Bowel Disease.

Authors:  Erkanda Ikonomi; Robin D Rothstein; Adam C Ehrlich; Frank K Friedenberg
Journal:  J Gastroenterol Pancreatol Liver Disord       Date:  2016-01-27

6.  European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.

Authors:  E F Stange; S P L Travis; S Vermeire; C Beglinger; L Kupcinkas; K Geboes; A Barakauskiene; V Villanacci; A Von Herbay; B F Warren; C Gasche; H Tilg; Stefan W Schreiber; J Schölmerich; W Reinisch
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 7.  Current application of proteomics in biomarker discovery for inflammatory bowel disease.

Authors:  Patrick Py Chan; Valerie C Wasinger; Rupert W Leong
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

8.  Management of growth failure in Crohn's disease.

Authors:  J A Walker-Smith
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

9.  Predicting Outcomes and Tailoring Therapy in the Diagnosis and Treatment of IBD.

Authors:  Ellen J Scherl; Ernest G Seidman; Douglas C Wolf
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-12

Review 10.  Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.

Authors:  Jason Orlando Dimitri Musci; Jack Stephen Cornish; Jan Däbritz
Journal:  J Gastroenterol       Date:  2016-03-14       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.